Intra-Cellular Therapies Inc. (ITCI) - Uzoq muddatli majburiyatlarning kapitalga nisbati

Intra-Cellular Therapies, Inc. - ITCI emitenti grafik logotipi

GURU.Markets platformasidagi Intra-Cellular Therapies (ITCI) kompaniyasining bozor qiymatini ko'rsatuvchi va 0.01 qiymatini aks ettiruvchi ushbu grafik, bipolar buzilish va shizofreniyani davolash uchun mo'ljallangan dori vositasining sotuvidan olinadigan barqaror pul oqimiga asoslangan. Biroq, tushumning yagona mahsulotga yuqori konsentratsiyasi sug'urta limitlariga nisbatan zaiflikni yuzaga keltiradi. Kompaniyaning kelgusidagi o'sishi tasdiqlangan ko'rsatmalarning ro'yxatini kengaytirish va yangi bemorlar guruhlari uchun terapiya imkoniyatlarini oshirishga bog'liq.

intracellulartherapies.com (ITCI): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 13.04.2025gacha

Intra-Cellular Therapies Inc. (ITCI) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Intra-Cellular|ITCI - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Intra-Cellular Therapies, Inc.|ITCI - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Intra-Cellular Therapies|ITCI - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati intracellulartherapies.com|ITCI - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Intra-Cellular Therapies|ITCI - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Intra-Cellular|ITCI - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Intra-Cellular Therapies, Inc.|ITCI - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Intra-Cellular Therapies|Oraliq qoplash koeffitsiyenti intracellulartherapies.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
ITCI - Sof foyda
Kompaniyaning har tomonlama tahlili:intracellulartherapies.com ITCI
intracellulartherapies.com original mahsuloti

Ushbu ko'rsatkich sof aktivlarda uzoq muddatli qarzlarning ulushini o'lchab, moliyaviy leveraj darajasini va rentabellikka tushadigan yukni belgilaydi. Intra-Cellular Therapies uchun ushbu muvozanat CAPLYTA sotuvlarini kengaytirishda hal qiluvchi ahamiyatga ega. Uzoq muddatli moliyaviy leverajning joriy darajasini tahlil qilish orqali investor kapitalning qarzlar xizmatini ko'rsatishga chidamliligini baholaydi. Past qiymatlar bankrotlik xavfini minimallashtirib, biofarmatsevtika biznesining fundamental barqarorligini tasdiqlaydi.

Raqobatdosh kompaniyalar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|harmonybiosciences.com (HRMY) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|Amylyx Pharmaceuticals Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Trevi Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati PRAX (Praxis Corp)|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CBLL (ceribell.com)|PRTA: Uzoq muddatli qarzning kapitalga nisbati|Alector (ALEC) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|OMER - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzning o'z kapitaliga nisbati acimmune.com ACIU|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|Neumora (NMRA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|TVGN: Uzoq muddatli qarzning o'z kapitaliga nisbati|alphacognition.com (ACOG) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CGTX (cogrx.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati IKT|Uzoq muddatli qarzning kapitalga nisbati Cassava Sciences Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|Uzoq muddatli qarzning o'z kapitaliga nisbati COYA (coyatherapeutics.com)|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Uzoq muddatli qarzning kapitalga nisbati Ovid Therapeutics Inc OVID|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CRVO (CervoMed, Inc.)|ATHE (alteritytherapeutics.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Clene - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati PEPG|JUNS (jupiterneurosciences.com) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati RLMD|ANVS (Annovis Bio Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati GRCE (Grace Therapeutics)|Firefly Neuro (AIFF) - Uzoq muddatli majburiyatlarning kapitalga nisbati|KLTO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti NRSN (NeuroSense Therapeutics)|RVPH: Uzoq muddatli qarzning kapitalga nisbati|MetaVia (MTVA) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeurAxis, Inc|Helius Medical Technologies Inc. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati PASG|Uzoq muddatli qarzdorlikning kapitalga nisbati bionomics.com.au|Uzoq muddatli qarzning kapitalga nisbati NERV (Minerva Neurosciences, Inc.)|Athira Pharma Inc (ATHA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ADXN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Alzamend Neuro, Inc. ALZN|CYCN: Uzoq muddatli qarzning kapitalga nisbati|PTIX - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati KTTA|CRGT (Cortigent Medical) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ATXI|Uzoq muddatli qarzning o'z kapitaliga nisbati BrainStorm Cell Therapeutics Inc. BCLI|Uzoq muddatli qarzning kapitalga nisbati CARA (Cara Therapeutics, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati chromocell.com (CHRO)|ELYM - Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH (Longboard Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|MRNS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp (NKGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO|Uzoq muddatli qarzning kapitalga nisbati sagerx.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN (Trevena Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical Inc. (WENA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati